| [1]DIMAIO D,LIAO J B.Human papillomaviruses and cervical cancer[J].Adv Virus Res,2006,66:125-159.
[2]薛旻,俞文菊,朱凯.宫颈癌及癌前病变中IL-17表达和HPV感染的相关性研究[J].中华肿瘤防治杂志,2011,18(9):701-703.
XUE M,YU W J,ZHU K.Expression of IL-10 in cervical cancer and precancerous lesion and its correlation with HPV infection[J].Chinese Journal of Cancer Prevention and Treatment,2011,18(9):701-703.
[3]WOODMAN C B,COLLINS S I,YOUNG L S.The natural history of cervical HPV infection:unresolved issues[J].Nat Rev Cancer,2007,7(1):11-22.
[4]SHEU B C,CHANG W C,LIN H H,et al.Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia[J].J Obstet Gynaecol Res,2007,33(2):103-113.
[5]杨丽娟.Th17 细胞抗肿瘤作用及其机制研究[D].石家庄:河北医科大学,2010.
[6]童丹,宋文静.IL-17、IL-6和TGF-β1在宫颈上皮内瘤变和宫颈癌中的表达及临床意义[J].中国妇幼保健,2014,29(24):3984-3986.
TONG D,SONG W J.Expressions and clinical significances of IL-17,IL-6 and TGF-β1 in cervical intraepithelial neoplasia and cervical cancer[J].Maternal & Child Health Care of China,2014,29(24):3984-3986.
[7]DAS P M,SINGAL R.DNA methylation and cancer[J].J Clin Oncol,2004,22(22):4632-4642.
[8]谢幸,苟文丽.妇产科学[M].北京:人民卫生出版社,2013:306-307.
[9]朱雄增.学习和掌握肿瘤的WHO分类,提高病理诊断和研究的水平[J].中华病理学杂志,2006,35(11):646-650.
ZHU X Z.Understanding WHO classification of tumors[J].Chinese Journal of Pathology,2006,35(11):646-650.
[10]马冬,于晓牧,吴尚青,等.IL-10-592多态性与唐山地区汉族女性HPV相关性宫颈癌[J].中国妇幼保健,2011,26(2):172-175.
MA D,YU X M,WU S Q,et al.Study on IL-10-592A/C polymorphism in high risk-HPV16/18-associated cervical carcinoma in Tangshan[J].Maternal & Child Health Care of China,2011,26(2):172-175.
[11]WILKE C M,KRYCZEK I,WEI S,et al.Th17 cells in cancer:help or hindrance?[J].Carcinogenesis,2011,32(5):643-649.
[12]CHERNOV A V,STRONGIN A Y.Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer[J].Biomol Concepts,2011,2(3):135-147.
[13]HASHIMOTO K,OTERO M,IMAGAWA K,et al.Regulated transcription of human matrix metalloproteinase 13 (MMP 13) and interleukin-1β(IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites[J].J Biol Chem,2013,288(19):10061-10072.
[14]CAMPOS K,GOMES C C,DE FTIMA CORREIA-SILVA J,et al.Methylation pattern of IFNG in periapical granulomas and radicular cysts[J].J Endod,2013,39(4):493-496.
[15]青文婕,吕莎,侯倩男,等.白细胞介素-17 在妇科肿瘤中的研究进展[J].中华妇幼临床医学杂志(电子版),2010,6(5):363-366.
QING W J,LYU S,HOU Q N,et al.Updated progress of interleukin-17 in gynecological tumors[J].Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition),2010,6(5):363-366.
[16]邓康丽.IL-17对人宫颈癌细胞株HeLa体外增殖的影响及作用机制的研究[D].长春:吉林大学,2013.
[17]吴文婷.IL-17RC低甲基化影响葡萄膜炎的机制研究及中药治疗葡萄膜炎的临床体会[D].北京:北京中医药大学,2014.
[18]BENARD V B,WATSON M,CASTLE P E,et al.Cervical carcinoma rates among young females in the United States[J].Obstet Gynecol,2012,120(5):1117-1123.
[19]张哲雄,徐承来,曹永涛.高危型人乳头状病毒和IL-17在宫颈病变患者宫颈脱落细胞中表达的相关性和临床意义[J].中国实验诊断学,2012,16(2):252-254.
ZHANG Z X,XU C L,CAO Y T.Correlations between human papillomavirus testing and Interleukin-17 in cervical exfoliated cells with cervical cancer and its clinical significonce[J].Chinese Journal of Laboratory Diagnosis,2012,16(2):252-254.
[20]薛纪森,陈骋,朱华,等.IL-17 在高危型HPV阳性宫颈癌中的表达[J].温州医科大学学报,2016,46(1):24-27.
XUE J S,CHEN C,ZHU H,et al.The expression of IL-17 in the cervical cancer with high-risk human papillomavirus infection[J].Journal of Wenzhou Medical University,2016,46(1):24-27.
[21]宋利.宫颈癌患者血清中IL-17水平的检测及临床意义[J].现代预防医学,2012,39(19):4966-4967.
SONG L.Detection and clinical significance of cervical cancer patients’ serum IL-17 level[J].Modern Preventive Medicine,2012,39(19):4966-4967. |